Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Heparin Crisis Spurs Changes In FDA Emergency Response Policies

Nov 15 2010

• By Sue Sutter

Related Content

Heparin Crisis Leads To New FDA Policy On Consulting Outside Experts

Nov 09 2010

Amphastar Lawsuit Over Heparin Shipments Suggests <i>Lovenox</i> ANDA Approval May Be Far Off

Nov 01 2010

FDA Approves Momenta/Sandoz' Lovenox Generic Without Need For Clinical Studies

Jul 26 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window